Literature DB >> 22472925

Frequency of rheumatic diseases in Portugal: a systematic review.

Teresa Monjardino1, Raquel Lucas, Henrique Barros.   

Abstract

OBJECTIVES: To describe the frequency of rheuma­tic diseases in Portugal through a systematic review of published literature, critically appraising available information and identifying data collection gaps.
METHODS: We systematically reviewed the literature to retrieve data on the occurrence of rheumatic diseases in Portugal through MEDLINE and Índex das Revistas Médicas Portuguesas searches, PhD theses, and national health surveys reports. Original articles in English or Portuguese published between 1 January 2000 and 31 December 2010 were included.
RESULTS: We retrieved information for the prevalence of rheumatic diseases, osteoarthritis, back pain, work-related musculoskeletal disorders (WRMDs), osteoporosis, fibromyalgia, rheumatoid arthritis, spondyloarthritis and other systemic rheumatic diseases and for the incidence of back pain, osteoporotic fracture and other systemic rheumatic diseases. The prevalence of rheumatic diseases ranged from 16.0% to 24.0% and the prevalence of osteoarthritis was 11.1% (95% confidence intervals (95%CI): 9.4-13.1) in the knee and 5.5% (95%CI: 4.3-7.0) in the hip. Regarding back pain, period prevalence ranged from 8.0% (95%CI: 6.1-10.1) to 29.5% (95%CI: 23.4-36.2) in children and from 12.3% (95%CI: 10.5-14.3) to 51.3% (95%CI: 48.6-53.9) in adults. The prevalence of WRMDs ranged from 5.9% to 84.2% (95%CI: 80.8-87.3). The yearly incidence of osteoporotic fracture (per 100 000) ranged from 93.3 to 481 (95%CI: 407-564) in women and from 31.9 to 154 (95%CI: 106-218) in men. The prevalence of osteoporosis in women ranged from 11.0% to 15.4% (95%CI: 13.4-17.6) and in men from 1.1% to 16.8% (95%CI: 12.2-22.3). The prevalence of fibromyalgia ranged from 3.6% (95%CI: 2.0-5.2) to 3.7% (95%CI: 2.0-5.4). The prevalence estimates of ankylosing spondylitis and of spondyloarthritis were 0.6% and 1.6% (95%CI: 0.8-2.7), respectively. The prevalence of systemic lupus erythematosus was estimated in 0.2% (95%CI: 0.1-0.8).
CONCLUSIONS: There is a broad spectrum of information available that indicates an important burden of rheumatic diseases in the general Portuguese population. Gaps were identified particularly regarding inflammatory arthropathies and other systemic rheumatic diseases.

Entities:  

Mesh:

Year:  2011        PMID: 22472925

Source DB:  PubMed          Journal:  Acta Reumatol Port        ISSN: 0303-464X            Impact factor:   1.290


  5 in total

1.  Association of GSTM1, GSTT1, GSTP1-ILE105VAL and ACE I/D polymorphisms with ankylosing spondylitis.

Authors:  Esra Erkol İnal; Orhan Görükmez; Selma Eroğlu; Özlem Görükmez; Özlem Solak; Ali Topak; Tahsin Yakut
Journal:  Rheumatol Int       Date:  2015-07-18       Impact factor: 2.631

2.  Prevalence of ankylosing spondylitis in Poland and costs generated by AS patients in the public healthcare system.

Authors:  A Śliwczyński; F Raciborski; A Kłak; M Brzozowska; T Czeleko; B Kwiatkowska; T Jędrzejczyk; M Marczak
Journal:  Rheumatol Int       Date:  2015-03-13       Impact factor: 2.631

Review 3.  Future perspectives of Smartphone applications for rheumatic diseases self-management.

Authors:  Ana Rita Pereira Azevedo; Hugo Manuel Lopes de Sousa; Joaquim António Faria Monteiro; Aurea Rosa Nunes Pereira Lima
Journal:  Rheumatol Int       Date:  2014-08-29       Impact factor: 2.631

4.  Portuguese adaptation and validation of a patient-reported experience measure for patients with rheumatoid arthritis: A protocol study.

Authors:  Daniela Oliveira; Miguel Bernardes; Carlos Vaz; Lúcia Costa; João Almeida Fonseca; Cristina Jácome
Journal:  Porto Biomed J       Date:  2022-09-09

Review 5.  Future of Rehabilitation Interventions for Rheumatic Patients in the Mediterranean Region.

Authors:  Aysen Akinci; Gamze Kiliç
Journal:  Mediterr J Rheumatol       Date:  2017-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.